Quoin Pharmaceuticals (QNRX) Enterprise Value (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Enterprise Value of -$14.0 million for Q1 2026, up 25.08% sequentially from -$18.7 million in Q4 2025, and down 267.42% YoY from $8.4 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Enterprise Value (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Enterprise Value for 10 years, with the latest figure at -$14.0 million in Q1 2026.
- Quarterly Enterprise Value fell 267.42% year-over-year to -$14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.0 million (down 267.42% YoY) and the FY2025 annual result came in at -$18.7 million, down 33.35% from the prior year.
- Enterprise Value rose to -$14.0 million in Q1 2026 per QNRX's latest filing, from -$18.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.7 million in Q2 2025 and troughed at -$18.7 million in Q4 2025.
- A 5-year average of -$5.6 million and a median of -$3.3 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 61.77% in 2022, then plunged 485.41% in 2024.
- Over 5 years, Enterprise Value stood at -$2.9 million in 2022, then grew by 16.06% to -$2.4 million in 2023, then slumped by 485.41% to -$14.1 million in 2024, then tumbled by 33.35% to -$18.7 million in 2025, then advanced by 25.08% to -$14.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$14.0 million, -$18.7 million, and -$5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | -10.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.04 Mn |
| Dec 31, 2025 | -18.75 Mn |
| Sep 30, 2025 | -5.41 Mn |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -3.82 Mn |
| Dec 31, 2024 | -14.06 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | -1.83 Mn |
| Dec 31, 2023 | -2.40 Mn |
| Sep 30, 2023 | -3.20 Mn |
| Jun 30, 2023 | -4.80 Mn |
| Mar 31, 2023 | -3.40 Mn |
| Dec 31, 2022 | -2.86 Mn |
| Sep 30, 2022 | -5.25 Mn |
| Jun 30, 2022 | -2.69 Mn |
| Dec 31, 2021 | -7.48 Mn |
| Dec 31, 2020 | -323,832.00 |
| Jun 30, 2020 | -7.00 Mn |
| Jun 30, 2019 | -7.64 Mn |